FX Multitech IPO Details: Price, Dates & Financials
The FX Multitech IPO is a closed SME Bookbuilding offer (Fresh capital cum OFS) that opened on 21 September 2026. The FX Multitech IPO closed on 23 September 2026, with an issue price of ₹116 per share. The FX Multitech IPO has a face value of ₹10 and a lot size of 1,200 shares. The FX Multitech IPO size aggregates up to ₹45 crore, listing on BSE SME on 28 September 2026. The FX Multitech IPO allotment was scheduled for 24 September 2026.
On the financial front, the FX Multitech IPO reported revenue of ₹112 crore for 31 Mar 2026, compared with ₹102 crore for 31 Mar 2025. The FX Multitech IPO PAT was ₹12 crore against ₹10 crore. The FX Multitech IPO EBITDA stood at ₹17 crore with a 15.35% margin. The FX Multitech IPO net worth as of 31 Mar 2026 was ₹38 crore.
Always verify The FX Multitech IPO details and GMP data with the official offer document before investing in the FX Multitech IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
73
61
33
Revenue
112
102
69
PAT
12
10
4
EBITDA
17
14
7
Net Worth
38
26
17
Reserves
27
16
16
Total Borrowing
18
17
11
FX Multitech IPO Financials FAQs
Revenue of FX Multitech (Amount in ₹ Crore) — 31 Mar 2026: 112; 31 Mar 2025: 102; 31 Mar 2024: 69. Profit after tax (PAT) — 31 Mar 2026: 12; 31 Mar 2025: 10; 31 Mar 2024: 4.
EBITDA of FX Multitech (Amount in ₹ Crore) — 31 Mar 2026: 17; 31 Mar 2025: 14; 31 Mar 2024: 7. The EBITDA margin is 15.35%.
Total assets — 31 Mar 2026: 73; 31 Mar 2025: 61; 31 Mar 2024: 33. Net worth — 31 Mar 2026: 38; 31 Mar 2025: 26; 31 Mar 2024: 17. Reserves & surplus — 31 Mar 2026: 27; 31 Mar 2025: 16; 31 Mar 2024: 16. (Amount in ₹ Crore)
Total borrowing of FX Multitech (Amount in ₹ Crore) — 31 Mar 2026: 18; 31 Mar 2025: 17; 31 Mar 2024: 11.
The financials shown for FX Multitech IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
